OTCMKTS:AFFY

Affymax Stock Forecast, Price & News

$0.04
0.00 (0.00 %)
(As of 07/23/2021 03:33 PM ET)
Add
Compare
Today's Range
$0.04
▼
$0.05
50-Day Range
$0.04
▼
$0.09
52-Week Range
$0.02
▼
$0.26
Volume7,600 shs
Average Volume49,035 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta2.81
30 days | 90 days | 365 days | Advanced Chart
Receive AFFY News and Ratings via Email

Sign-up to receive the latest news and ratings for Affymax and its competitors with MarketBeat's FREE daily newsletter.


Affymax logo

About Affymax

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Headlines

Affymax (OTCMKTS:AFFY) Shares Pass Above 200 Day Moving Average of $0.00
Affymax (OTCMKTS:AFFY) Shares Pass Above 200 Day Moving Average of $0.00
July 14, 2021 |  americanbankingnews.com
Affymax (OTCMKTS:AFFY) Shares Cross Above 200 Day Moving Average of $0.00
Affymax (OTCMKTS:AFFY) Shares Cross Above 200 Day Moving Average of $0.00
July 3, 2021 |  americanbankingnews.com
Dr. Mike Holfinger Joins Alladapt as Chief Technical Officer
Dr. Mike Holfinger Joins Alladapt as Chief Technical Officer
April 28, 2021 |  ca.finance.yahoo.com
PEGylated Protein Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
PEGylated Protein Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
December 29, 2020 |  marketwatch.com
Affymax IncShs - Profile
Affymax IncShs - Profile
August 16, 2020 |  markets.businessinsider.com
Affymax Inc.
Affymax Inc.
July 23, 2020 |  www.marketwatch.com
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Affymax, Inc. Class Action and Settlement
March 8, 2020 |  www.bloomberg.com
RubrYc Therapeutics Announces formation of its Scientific Advisory Board
RubrYc Therapeutics Announces formation of its Scientific Advisory Board
December 4, 2019 |  finance.yahoo.com
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel
July 11, 2019 |  www.marketwatch.com
Health Care Digest: Why another event is joining the JPM crowd, IPO ties that bind and more
Health Care Digest: Why another event is joining the JPM crowd, IPO ties that bind and more
December 31, 2018 |  www.bizjournals.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.60 out of 5 stars

Medical Sector

2953rd out of 4,434 stocks

Pharmaceutical Preparations Industry

1311th out of 1,734 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Affymax (OTCMKTS:AFFY) Frequently Asked Questions

What stocks does MarketBeat like better than Affymax?

Wall Street analysts have given Affymax a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Affymax wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Affymax's stock been impacted by COVID-19?

Affymax's stock was trading at $0.0386 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AFFY shares have increased by 3.6% and is now trading at $0.04.
View which stocks have been most impacted by COVID-19.

Who are Affymax's key executives?

Affymax's management team includes the following people:
  • Mr. Mark G. Thompson, CFO & Sec. (Age 59, Pay $97.49k)
  • Mr. Jonathan M. Couchman, CEO, Pres & Director (Age 51)
  • Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 58)

Who are some of Affymax's key competitors?

Some companies that are related to Affymax include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), Exact Sciences (EXAS), Incyte (INCY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX) and United Therapeutics (UTHR).
View all of AFFY's competitors.

What other stocks do shareholders of Affymax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Affymax investors own include (GRM.V) (GRM), (MCPIQ) (MCPIQ), Bank of America (BAC), The Boeing (BA), American Express (AXP), Aurinia Pharmaceuticals (AUPH), Actinium Pharmaceuticals (ATNM), Advanced Micro Devices (AMD), Alnylam Pharmaceuticals (ALNY) and Achaogen (AKAO).

What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

How do I buy shares of Affymax?

Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Affymax's stock price today?

One share of AFFY stock can currently be purchased for approximately $0.04.

How many employees does Affymax have?

Affymax employs 2 workers across the globe.

What is Affymax's official website?

The official website for Affymax is www.affymax.com.

Where are Affymax's headquarters?

Affymax is headquartered at 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014.

How can I contact Affymax?

Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]


This page was last updated on 7/26/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.